323 related articles for article (PubMed ID: 22106224)
1. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
2. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
3. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
Gutu AD; Sgambati N; Strasbourger P; Brannon MK; Jacobs MA; Haugen E; Kaul RK; Johansen HK; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2013 May; 57(5):2204-15. PubMed ID: 23459479
[TBL] [Abstract][Full Text] [Related]
4. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
5. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
[TBL] [Abstract][Full Text] [Related]
6. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
[TBL] [Abstract][Full Text] [Related]
7. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Barrow K; Kwon DH
Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
Abraham N; Kwon DH
FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
[TBL] [Abstract][Full Text] [Related]
9. Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient.
Lee JY; Lim MH; Heo ST; Ko KS
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):267-71. PubMed ID: 22217703
[TBL] [Abstract][Full Text] [Related]
10. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
11. Mutations in
Romano KP; Warrier T; Poulsen BE; Nguyen PH; Loftis AR; Saebi A; Pentelute BL; Hung DT
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235628
[No Abstract] [Full Text] [Related]
12. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
[TBL] [Abstract][Full Text] [Related]
13. Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. Coli strains.
Wang CH; Siu LK; Chang FY; Tsai YK; Huang LY; Lin JC
BMC Microbiol; 2024 Apr; 24(1):109. PubMed ID: 38565985
[TBL] [Abstract][Full Text] [Related]
14. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
[TBL] [Abstract][Full Text] [Related]
16. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
McPhee JB; Lewenza S; Hancock RE
Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375
[TBL] [Abstract][Full Text] [Related]
17. Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB.
Huang J; Li C; Song J; Velkov T; Wang L; Zhu Y; Li J
Future Microbiol; 2020 Apr; 15(6):445-459. PubMed ID: 32250173
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa high-level resistance to polymyxins and other antimicrobial peptides requires cprA, a gene that is disrupted in the PAO1 strain.
Gutu AD; Rodgers NS; Park J; Moskowitz SM
Antimicrob Agents Chemother; 2015 Sep; 59(9):5377-87. PubMed ID: 26100714
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
[TBL] [Abstract][Full Text] [Related]
20. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
